These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1707769)

  • 1. Analysis of CD1 molecules on haematological malignancies of myeloid and lymphoid origin. I. Cell surface antigen expression.
    Salamone MC; Roisman FR; Santiago J; Satz ML; Fainboim L
    Dis Markers; 1990; 8(5):265-74. PubMed ID: 1707769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of CD1 molecules on haematological malignancies of myeloid and lymphoid origin. II. Intracellular detection of CD1 antigens.
    Salamone MC; Roisman FR; Morelli AE; Noli MI; Fainboim L
    Dis Markers; 1990; 8(5):275-81. PubMed ID: 1707770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
    Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
    Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O; Glasová M; Koníková E; Kusenda J
    Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
    Hashimi L; Wang CY; Al-Katib A; Koziner B
    Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies.
    Foroni L; Catovsky D; Rabbitts TH; Luzzatto L
    Mol Biol Med; 1984 Feb; 2(1):63-79. PubMed ID: 6439975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leu-M1 antigen expression in acute leukaemias.
    de Mascarel A; Coindre JM; de Mascarel I; David B; Trojani M; Broustet A
    J Pathol; 1987 Nov; 153(3):225-32. PubMed ID: 3501459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
    Klobusická M; Babusíková O
    Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
    Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of cytoplasmic antigens in acute leukemia by flow cytometry].
    Kawai S; Zha Z; Yamamoto Y; Nakadate H; Kawakami K; Kikuta A; Utsumi J; Nishikawa K; Mimaya J; Miyake M
    Rinsho Ketsueki; 1993 Jan; 34(1):13-20. PubMed ID: 8450602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
    Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
    J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies.
    Marinov J; Koubek K; Starý J
    Neoplasma; 1993; 40(6):355-8. PubMed ID: 8289967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MHC class I associated beta 2-microglobulin (beta 2m) light chain is expressed in a molar excess over HLA-ABC and CD1 on the membrane of leukaemic B cells but not leukaemic T cells: evidence for further beta 2m-associated molecules.
    Jones RA; Child JA; Master PS; Scott CS
    Scand J Immunol; 1991 Jul; 34(1):53-61. PubMed ID: 1712510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides.
    Rani S; De Oliveira MS; Catovsky D
    Hematol Pathol; 1988; 2(2):73-8. PubMed ID: 2974027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells.
    Belov L; Huang P; Chrisp JS; Mulligan SP; Christopherson RI
    J Immunol Methods; 2005 Oct; 305(1):10-9. PubMed ID: 16125720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of HLA-DR antigens on leukaemic cells.
    Newman RA; Greaves MF
    Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.